Results of ablation therapy for hepatocellular carcinoma

Abstract

Results of ablation therapy was clinically evaluated for 38 hepatocellular carcinoma (HCC) patients. Their age, ICG, and tumor diameter was 68 years, 34%, 28 mm, respectively. Three-year survival rate was 77%. Ablation therapy was a good choice for poor risk patient with small sized tumor despite of remaining some problems such as liver abscess, needle tract burn and remnant viable cells due to radiator effect.